IA
SKYE icon

IFP Advisors’s Skye Bioscience SKYE Stock Holding History

IFP Advisors’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
2
+1
+100% +$1 ﹤0.01% 5013
2025
Q4 		$1 Hold
1
– – ﹤0.01% 4880
2025
Q3 		$4 Buy
+1
New +$4 ﹤0.01% 4816
2025
Q1 		– Sell
-3
Closed -$8 – 4678
2024
Q4 		$8 Hold
3
– – ﹤0.01% 4546
2024
Q3 		$12 Hold
3
– – ﹤0.01% 3282
2024
Q2 		$24 Buy
+3
New +$36 ﹤0.01% 3199

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

IFP Advisors's SKYE Position: Q1 2026 in Review

IFP Advisors increased its Skye Bioscience (SKYE) stake by 100% in Q1 2026, buying an estimated $1 and bringing the position to 2 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5013.

IFP Advisors first reported a position in SKYE in Q2 2024 and has held it in 6 quarters since. The position peaked at $24 in Q2 2024. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • IFP Advisors held 2 shares of Skye Bioscience worth $1 as of Q1 2026.
  • IFP Advisors bought 1 Skye Bioscience share in Q1 2026, an estimated $1.
  • Skye Bioscience made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #5013 holding.
  • IFP Advisors first reported a position in Skye Bioscience in Q2 2024 and has held it in 6 quarters since.
  • IFP Advisors's Skye Bioscience position peaked at $24 in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.